Health Systems Change
The transformation of healthcare throughout our country has created new opportunities to implement systematic changes to reduce tobacco use, improve overall heath, and enhance services, all while reducing healthcare costs. As promoted by the CDC’s Best Practices for Comprehensive Tobacco Control Programs, EAHEC works closely with statewide and local healthcare organizations to assist with the institutionalization of tobacco cessation interventions into routine clinical care. This process helps to ensure that every patient is screened for tobacco use, are advised to quit, and provided with the support and resources needed to stop using tobacco.
EAHEC can provide support to organizations with their delivery system design, referral process, clinical information on tobacco cessation, as well as standardizing and delivering regular tobacco cessation education and training to the organization’s staff.
Behavioral Health Initiative
According to new findings from researchers at the CDC, Americans with mental health conditions have a 70% greater likelihood of smoking than the general population. Participation in tobacco cessation efforts while engaged in other substance abuse treatment has been associated with a 25% greater likelihood of long-term abstinence from alcohol and other drugs. EAHEC works with behavioral health facilities to provide cessation services to help clients quit using tobacco and support their recovery efforts.
Importance to Healthcare Insurers
Health insurance coverage of tobacco cessation treatment increases both use of effective treatment and the number of successful quit attempts.1 The U.S. Public Health Service (USPHS) report Treating Tobacco Use and Dependence: A Clinical Practice Guideline, recommends that healthcare insurers should “include [effective] smoking cessation treatments (both pharmacotherapy and counseling)…as paid services for all subscribers.”2,3 In 2010, the Affordable Care Act (ACA) took a major step to address the significant human life and financial costs of tobacco use in the U.S. by requiring insurance companies and employers to cover tobacco cessation treatment services recommended in the USPHS guidelines with no cost sharing. Unfortunately, private insurance coverage for tobacco cessation services is still relatively uncommon.4
Recommendations for Insurance Health Plan Providers
Insurance providers are in a unique position to reduce the burden of disease associated with tobacco use in their subscriber populations by adhering to the following recommendations:
Recommendation: Health insurance providers should include effective tobacco cessation treatments as paid or covered services for all subscribers.5
- Seven medications and three types of counseling are recommended to treat tobacco dependency. Nicotine replacement therapies (NRTs) are available over-the-counter (patch, gum, lozenge) and by prescription (nasal spray, inhaler), while bupropion (Zyban) and varenicline (Chantix) are two non-nicotine, prescription-only options.5
- The types of counseling include individual (either face-to-face or telephone) and group counseling.5
- Coverage should be provided for at least two cessation attempts per year.6
- Having access to all these treatments increases the likelihood of successful cessation among tobacco users.5
- Quit rates are higher when health insurance covers tobacco cessation treatments.5
Recommendation: Health insurance providers should remove arbitrary barriers that limit access to cessation treatments.5, 7
- Barriers that deny or limit treatment include:
- Requiring co-pays;
- Limiting the length, frequency or amount spent on treatments;
- Requiring prior authorization;
- Requiring quit attempts with one medication before trying another;
- And requiring counseling to be paired with medication. 8
- Conflicting and confusing contract language also may leave subscribers uncertain if tobacco cessation treatments are covered, which could discourage them from seeking these treatments.9
- Removing barriers will encourage more people to use the benefit and successfully quit tobacco.
- Hopkins DP. Recommendations to improve targeted vaccination coverage among high-risk adults – Task force on community preventive services. American Journal of Preventive Medicine. Jun 2005;28(5):231-237.
- Fiore MC. AHCPR smoking cessation guideline: a fundamental review. Tob Control. 1997;6 Suppl 1:S4-8.
- Fiore MC, et al. Clinical Practice Guideline: Treating tobacco use and dependence: 2008 Update. Rockville, MD: US Dept of Health and Human Services, Public Health Service; 2008.
- Schauffler HH. Defining benefits and payment for smoking cessation treatments. Tob Control. 1997;6 Suppl 1:S81-85.
- Fiore MC, et al. Clinical Practice Guideline: Treating tobacco use and dependence: 2008 Update. Rockville, MD: US Dept of Health and Human Services, Public Health Service; 2008. [pdf]
- George Washington University Center for Health Services Research and Policy. Sample Purchasing Specifications Related To Tobacco-Use Prevention And Cessation: a Technical Assistance Document. October 2002. [pdf]
- Centers for Disease Control and Prevention, American Cancer Society, and Wellness Councils of America. Making Your Workplace Smokefree—A Decision Maker’s Guide. 1996. [pdf]
- American Lung Association. Helping Smokers Quit: State Cessation Coverage; 2011
- Kofman M, Dunton, K., Senkewicz, MB. Implementation of tobacco cessation coverage under the Affordable Care Act: Understanding how private health insurance policies cover tobacco cessation treatments. Washington, D.C.: Georgetown Health Policy Institute;2012.
- Fitch K, Iwasaki, K., & Peyenson, B. Covering smoking cessation as a health benfit: A case for employers. 2006.
- Curry SJ, Grothaus LC, McAfee T, Pabiniak C. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. N Engl J Med. Sep 3 1998;339(10):673-679.
- Richard P, West K, Ku L. The return on investment of a Medicaid tobacco cessation program in Massachusetts. PLoS One. 2012;7(1):e29665.
- Halpern MT, Khan ZM, Young TL, Battista C. Economic model of sustained-release bupropion hydrochloride in health plan and work site smoking-cessation programs. Am J Health Syst Pharm. Aug 1 2000;57(15):1421-1429.